Cyclin E expression and proliferation in breast cancer

Citation
Nh. Nielsen et al., Cyclin E expression and proliferation in breast cancer, ANAL CELL P, 17(3), 1998, pp. 177-188
Citations number
32
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
ANALYTICAL CELLULAR PATHOLOGY
ISSN journal
09218912 → ACNP
Volume
17
Issue
3
Year of publication
1998
Pages
177 - 188
Database
ISI
SICI code
0921-8912(1998)17:3<177:CEEAPI>2.0.ZU;2-B
Abstract
Cyclin E is a part of the cell cycle machinery and aberrantly expressed in several malignancies including breast cancer. Since cyclin E is cell cycle specifically expressed, we wanted to examine the relation between prolifera tion and expression of cyclin E with special attention to tumours with over expression of the protein. Seventy-four breast tumours were analysed for th e expression of cyclin E by immunohistochemistry and Western blotting and r elated to the growth fraction determined by Ki-67. Significant correlations were obtained between the growth fraction, the percentage of cyclin E posi tive cells, the intensity of cyclin E and total amount of cyclin E determin ed by Western blotting. The majority of the tumours had less cyclin E than Ki-67 positive cells indicating a conserved cell cycle specific expression of the protein which further was supported by flow cytometric analysis of b reast cancer cell lines. The cell cycle specificity of cyclin E was found e ven in rumours with inactivated retinoblastoma protein (pRB) demonstrating the existence of a pRB independent regulation of cyclin E. A fraction of th e tumours had considerably elevated cyclin E levels that were not in relati on to the proliferative activity as observed for the other tumours. These t umours were in general highly proliferative and considered to overexpress c yclin E. Patients with rumours of high proliferative activity, high total c yclin E levels or disproportionally elevated cyclin E expressions in relati on to proliferation had significantly increased risk of death in breast can cer, whereas the intensity of the immunohistochemical cyclin E staining did not affect the survival.